DeutschNewstral
Article
bizjournals.com on 2021-12-22 21:00
Morrisville drugmaker acquiring firm behind anthrax treatment
Related news
- Morrisville drugmaker scores $6M deal with Canada for anthrax treatmentbizjournals.com
- Triangle drugmaker acquiring firm behind anthrax treatmentbizjournals.com
- Morrisville drugmaker raises $21.7M to push ahead with hypertension treatmentbizjournals.com
- Morrisville drugmaker earns go ahead for trials on new cancer treatmentbizjournals.com
- Morrisville firm explores potential COVID-19 treatment, raises $8 millionbizjournals.com
- Morrisville firm scores 'huge' federal contract – up to $77M – for E. coli treatmentbizjournals.com
- Morrisville pharma makes all-stock deal for Illinois firm developing treatment for hypertensionbizjournals.com
- Morrisville firm gets tentative FDA approval for hypertension treatment amid lawsuitbizjournals.com
- Morrisville drugmaker says Covid vaccine candidate produces desired effectbizjournals.com
- Morrisville drugmaker secures $25M to boost manufacturing, discovery effortsbizjournals.com
- Morrisville drugmaker hits halfway mark toward $20M raisebizjournals.com
- Morrisville heart tech firm scores $6.7Mbizjournals.com
- Florida firm plans more apartments for Morrisvillebizjournals.com
- Raleigh hotel firm acquires Morrisville office buildingbizjournals.com
- Morrisville firm buys Arizona, Michigan companiesbizjournals.com
- Semiconductor firm Renesas taps Morrisville for expansionbizjournals.com
- Morrisville tobacco firm cuts 565 NC jobsbizjournals.com
- Morrisville drugmaker changing name, subsidiary plans $650M manufacturing facility in Kansasbizjournals.com